Chi-Med creates new structure and outperforms forecasts - New version
This article was originally published in Scrip
Executive Summary
Hutchinson China Meditech (Chi-Med) has reported strong first-half 2008 results and is looking to unlock the value of its wholly owned drug R&D business, Hutchinson Medipharma Holdings Limited (HMHL).